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Abstract
Groups of patients with idiopathic
Parkinson's disease, multiple system
atrophy, and progressive supranuclear
palsy or Steele-Richardson-Olszewski
syndrome, matched for overall clinical
disability, were compared using three
computerised cognitive tests previously
shown to be sensitive to frontal lobe dys-
function. On a test of planning based on
the Tower of London task, all three
groups were impaired, but in different
ways. The groups with palsy and
Parkinson's disease were slower in the
measure of initial thinking time, whereas
the group with multiple system atrophy
was only slower in a measure of thinking
time subsequent to the first move,
resembling patients with frontal lobe
damage. On a test of spatial working
memory, each group showed deficits rel-
ative to their matched control groups,
but the three groups differed in their
strategy for dealing with this task. On a
test of attentional set shifting, each group
was again impaired, mainly at the
extradimensional shifting stage, but the
group with Steele-Richardson-Olszewski
syndrome exhibited the greatest deficit.
The results are compared with previous
findings in patients with Alzheimer's dis-
ease or frontal lobe damage. It is con-
cluded that these basal ganglia disorders
share a distinctive pattern of cognitive
deficits on tests of frontal lobe dysfunc-
tion, but there are differences in the
exact nature of the impairments, in com-
parison not only with frontal lobe dam-
age but also with one another.
(TNeurol Neurosurg Psychiatry 1994;57:79-88)
There is now overwhelming evidence that
patients with basal ganglia disorders, includ-
ing those with Parkinson's disease,
Huntington's disease and progressive
supranuclear palsy (or the Steele-Richardson-
Olszewski syndrome, SRO), can exhibit char-
acteristic cognitive deficits.' However, the
precise nature of these deficits, as well as their
neural substrates, are still matters for debate.
They appear to be different from those seen
early in the course of Alzheimer's disease.2-5
For Parkinson's disease, some investigators
have emphasised the 'frontal' or 'fronto-stri-
atal' nature of the deficits,67 whereas others
have described relatively focal neuropsycho-
logical abnormalities that occur, for example,
in visuospatial function,8 and yet others have
emphasised the similarities of the deficits to a
syndrome of 'subcortical dementia'.9 10
The original paper describing this syn-
drome was, in fact, illustrated with reports of
several patients with SRO who exhibited for-
getfulness, slowness of thought, changes in
personality with apathy and depression, and
an impaired ability to manipulate acquired
knowledge. Others have also emphasised the
frontal-lobe like nature of the deficits in SRO
because of the failure of patients with SRO
on classic tests of frontal lobe function such
as the Wisconsin card sorting test and verbal
fluency, as well as their tendency to exhibit
frontal lobe 'signs', including enhanced grasp
reflexes, motor impersistence, and utilisation
behaviour."213 Indeed two of these studies'21'
showed that the two groups with Parkinson's
disease and SRO matched for age and sever-
ity of intellectual deterioration, were impaired
on tests of frontal lobe dysfunction, the group
with SRO performing worse. From these
studies of basal ganglia dysfunction, it is
apparent that the relationship between the
cognitive deficits seen in 'subcortical demen-
tia' and frontal lobe dysfunction has yet to be
resolved.
In contrast to the extensive investigation of
cognitive dysfunction in these two conditions,
there has been relatively little analysis of pos-
sible intellectual deficits in other informative
progressive akinetic-rigid syndromes, which
include multiple system atrophy. This disease
is of particular interest for, in addition to the
intrinsic striatal (caudate plus putamen)
pathology, damage to the nigrostriatal
dopamine pathway (particularly to the cau-
date nucleus) is at least equal, or even
greater, to that seen in Parkinson's disease
and SRO."4 Unsurprisingly, therefore, multi-
ple system atrophy can initially prove difficult
to differentiate clinically from idiopathic
Parkinson's disease or SRO.15 Patients with
atrophy generally have Parkinsonism as a
major feature, attributed to striatonigral
degeneration, but with the frequent addi-
tional presence of pyramidal, autonomic
(Shy-Drager syndrome), or cerebellar (olivo-
pontocerebellar atrophy) signs.'57
79
Robbins,
_James, Owen, Lange, Lees, Leigh, Marsden, Quinn, Summers
The present study sought to compare
groups of patients in tasks recently shown to
be sensitive to frontal lobe dysfunction. These
included a test of attentional set shifting1819 a
test of planning based on the Tower of
London task202' and a test of spatial working
memory.21 The importance of these tests is
that, in certain cases, they have revealed sig-
nificant differences in the precise pattern of
deficits seen in various stages of Parkinson's
disease and in patients with neurosurgical
damage to the frontal lobes.22-24 This latter
group of patients are significantly less accu-
rate in their solutions to the Tower of
London problems, but no slower than normal
to initiate correct solutions.2' Patients with
Parkinson's disease with relatively mild clini-
cal disability, but sufficient to warrant treat-
ment, in contrast are no less accurate than
normal, but spend longer initially thinking
about their solutions.22-24 Moreover, the
patients with frontal lobe damage showed no
evidence of employing the most advantageous
strategy on the spatial working memory
task,2' whereas the patients with Parkinson's
disease, though showing equivalent overall
levels of cognitive dysfunction, did exhibit
evidence of using the strategy.22-24 A prelimi-
nary survey25 of the cognitive deficits in
patients with multiple system atrophy has
shown that they qualitatively resemble those
of patients with frontal lobe damage rather
than those with Parkinson's disease. These
findings raise the possibility that the symp-
toms of frontal lobe dysfunction versus stri-
atal damage may be differentiated using the
same tests. Consequently, as there has been
relatively little experimental detailed charac-
terisation of slowness of thinking in SRO, nor
of other frontal symptoms such as impaired
set shifting and working memory, a detailed
comparison with Parkinson's disease and
multiple system atrophy in tests sensitive to
frontal lobe dysfunction seemed to be war-
ranted.
Methods
SUBJECTS
Patients with Parkinson's disease
The 24 patients included in this study were
all outpatients at the Maudsley Hospital,
London. In all cases, idiopathic Parkinson's
disease was diagnosed by a consultant neurol-
ogist who also assessed the severity of clinical
Table 1 Patient characteristics
Stage Duration
Group (mean) n M:F Age NART (years)
SRO 3-8 18 9:9 64-1 (1-35) 108-7 (2-15) 4 7(0 8)
Controls 18 7:11 64-2 (1-66) 109-2 (1-6)
MSA 3-7 16 14:2 51-1 (1-99) 111-5 (2-25) 6 2(0 7)
Controls 16 8:8 54-6 (1 88) 112-6 (1 73)
PD 3-5 24 16:8 63 2 (2 46) 107 9 (2 56) 10 2(1 57)
Controls 24 7:17 61-5 (1-28) 111-6(1-34)
Standard errors are shown in parentheses. Stage = Hoehn & Yahr Stage26; NART = National
Adult Reading Test30; SRO = Steele-Richardson-Olszewski syndrome; MSA = Multiple
System Atrophy; PD = Parkinson's disease.
symptoms according to the Hoehn and Yahr
rating scale26 while the patients were on treat-
ment. All patients were receiving levodopa
preparations, to which they had responded,
either alone or in combination with other
medication.
Exclusion criteria for these patients
included clinical dementia assessed using
both the Mini-mental state examination
(MMSE)27 and the Kendrick object learning
test (KOLT).28
Patients with Steele-Richardson-Olszewski
Syndrome
The 18 patients with SRO were diagnosed at
the National Hospital for Neurology and
Neurosurgery and at the Maudsley Hospital,
London, according to the criteria set out by
Lees.29 The duration of disease averaged 4-7
years taken from the initial symptoms. Six
patients were on dopaminergic medication at
the time of testing and one patient was receiv-
ing anticholinergic medication.
Patients with multiple system atrophy
All 16 patients were diagnosed at the
National Hospital, according to criteria set
out by Quinn.'5 The duration of disease aver-
aged six years taken from the time of initial
symptoms. Only two of the 16 patients were
not receiving any medication. All the remain-
ing patients were receiving levodopa or
bromocriptine preparations. Two patients
were also receiving the anticholinergic drug
benzhexol.
Control subjects
Three groups of healthy control subjects
(n = 52) were chosen to match the groups of
patients, as closely as possible with respect to
age and premorbid verbal IQ as assessed
using the National adult reading test
(NART).30 These subjects were drawn from a
large pool of control volunteers at the North
East Age Research panel in Newcastle Upon
Tyne, United Kingdom.
In the attentional set shifting task, the
three patient groups were compared with a
large group of normal control volunteers (n =
79, mean age = 58-8 (SE = 0-9), mean
NART IQ 116.0 (0 9) between the ages of 41
and 69 drawn from the North East Age
Research panel in Newcastle Upon Tyne and
from the Newcastle, Cambridgeshire and
London areas. Informed consent was
obtained for all patients and normal volun-
teers.
Table 1 shows a summary of characteristics
for the three patient groups and their con-
trols. One way analysis of variance confirmed
that the patient groups were all well matched
with their respective control groups in terms
of age and NART IQ estimate. In terms of
the Hoehn and Yahr scale of clinical disabil-
ity, all patients received ratings of between III
and V. The distribution of these ratings (III
IV and V) was: multiple system atrophy, 8 5
3; Parkinson's disease 14 9 1; SOR 7 9 2.
Contingency table analysis of these scores
(see over) showed that there were no signifi-
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cant differences between the three groups in
the distribution of these scores (2i = 4-65, df
= 4; not significant).
MATERIALS AND PROCEDURES
The main testing procedures were taken from
the Cambridge Neuropsychological Test
Automated Battery (CANTAB), a series of
computerised paradigms run on an Acorn
BBC Master microcomputer with a high res-
olution Microvitec colour monitor and a
Microvitec (Touchtech 501) touch sensitive
screen. The general rationale and use of the
battery for clinical investigations has recently
been explained in some detail.23 Subjects
were seated approximately 0-5 m from the
monitor and it was explained that they would
have to respond to stimuli by touching the
screen.
Spatial short term memory task
In this computerised Corsi block tapping
task," spatial short term memory capacity
was determined from the ability of subjects to
remember a sequence of squares on the
screen, as described in detail in an earlier
publication.2' Spatial short term memory
span was calculated as the highest level at
which the subject successfully recalled at least
one sequence of boxes.
Spatial working memory task
In this task the subject was required to search
through spatial arrays of boxes to find tokens.
Importantly, once a blue token had been
found within a particular box, then that box
would never be used to hide another token.
On each trial, the total number of blue tokens
to be found corresponded to the number of
boxes on the screen, as every box was used
just once.
Errors were scored according to the num-
ber of occasions on which a subject returned
to open a box in which a blue counter had
already been found. After four practice trials
with three boxes, there were four test trials
with each of four, six, and finally eight, boxes.
In the present study, the three patient
groups were compared in terms of the total
number of errors summed across the 12 test
trials. One possible strategy for completing
this task is to follow a predetermined search
sequence, beginning with a particular box
and then returning to start each new
sequence with that same box as soon as a
token has been found. A previous investiga-
tion has shown that impaired performance on
this task may be related to inefficient use of
this particular search strategy in neurosurgical
patients with frontal lobe excisions.2' The
extent to which each group used this repeti-
tive searching pattern as a strategy for
approaching the problem was estimated from
the number of search sequences starting with
the same box, within each of the more diffi-
cult six and eight box problems. The total of
these scores provided a single measure of
strategy for each subject, with a high score
(many sequences beginning with a different
box) representing low use of the strategy and
a low score (many sequences starting with the
same box) representing more extensive usage.
Planning task
This is a modification of the Tower of
London task20 in which the subject has to
move coloured 'balls' on the screen from an
initial arrangement to one corresponding to
the goal arrangement shown in the top half of
the screen, as described in detail previ-
ously.2' 25
The starting position of the balls was var-
ied such that in any particular trial the solu-
tion could only be reached after a minimum
of two, three, four or five moves. Subjects
were instructed to examine the position of the
balls at the beginning of each problem and
attempt to solve it in the minimum possible
number of moves. This was both given to
them verbally and displayed on the screen
throughout each trial. They were encouraged
not to make the first move until they were
confident that they could execute the entire
sequence needed to solve the problem. The
maximum moves allowed corresponded to
twice the minimum number possible plus
one, or plus two in the case of 'five move'
problems.
For each test problem, a 'yoked control'
condition was employed to provide baseline
measures of motor initiation and execution
times. On each trial of this control condition,
the subject was required to follow a sequence
of single moves executed by the computer in
the top half of the screen by moving the cor-
responding ball in the lower arrangement.
The measurement of selection and execution
latencies in this control condition provided
baseline estimates of motor initiation and
execution times (see2' for further details).
Attention set shifting
The computerised attentional set shifting par-
adigm has been described in detail
elsewhere.'819 Briefly, subjects are trained on
a series of visual discriminations which vary
in two perceptual dimensions, one of which is
correct or relevant and one of which is incor-
rect or irrelevant, using feedback provided
automatically by the computer. At critical
points subjects are required first to maintain
attention to different examples within the
same dimension (intradimensional shift) and
then to shift attention to the previously irrele-
vant dimension (extradimensional shift). The
other stages are defined and explained in pre-
vious papers and in the Results section. For
each stage, continuation to the next one was
dependent on a criterion of six successive cor-
rect responses being reached. If criterion was
not reached by the 50th trial of a stage, then
the test was discontinued and subjects did
not proceed to the following stage. More
detailed explanation and rationales for the
exact design of the test can be found in previ-
ously published articles.'8 19 32-34
STATISTICAL ANALYSIS
For most of the dependent variables, analysis
of variance was used. Data were transformed
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where appropriate-that is, when there was a
positive skew on latency variables. For most
of the test variables, the analysis of variance
model was a two factor design that included a
between subjects factor (group) and a within
subject factor-for example, difficulty level.'5
As the group with multiple system atrophy
were younger and showed a tendency towards
a higher IQ than the other two patient
groups, the patient groups were each com-
pared with an appropriate age and IQ
matched control group.
For the attentional set shifting task, the
data for the numbers of subjects passing or
failing each stage of the test were cast into
contingency tables and analysed using the
likelihood ratio method.3637 This method is
particularly useful, firstly, for analysing data
with small cell frequencies, as occurs in some
of the data to be presented, and secondly, for
partitioning inhomogeneities in the contin-
gency table by additive, orthogonal con-
trasts.37 The resulting 'information' statistic
(2i) is distributed as X2.36
Results
SPATIAL SHORT TERM MEMORY TASK
The three patient groups were independently
compared with their respective control groups
in terms of the number of squares that were
touched in the correct serial order. Mean val-
ues and corresponding standard errors for the
six groups are shown in fig 1. One way analy-
ses of variance showed that the groups with
Parkinson's disease and SRO were signifi-
cantly impaired on this measure (F (1,46) =
15-86, p < 0-001 and F(1,34) = 7-65,
p < 0-01 respectively). In contrast, the
patients with multiple system atrophy were
not significantly impaired (F (1,30) = 2 9)
compared with their matched control group.
SPATIAL WORKING MEMORY TASK
The mean total numbers of 'between search
errors' made by the three patient groups and
Figure 1 Performance on
the spatial span task for
the groups with multiple
system atrophy (MSA),
Parkinson's disease (PD),
Steele-Richardson-
Olszewski syndrome
(SRO) and their matched
controls. Values shown are
mean maximum spans
(SE).
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their controls are presented in fig 2. There
was a highly significant difference between
the group with Parkinson's disease and their
controls (F (1,46) = 7-66, p < 0-01), between
the group with SRO and their controls
(F (1,34) = 7 49, p < 0-01) and between the
group with multiple system atrophy and their
controls (F(1,35) = 5-45, p < 0 05). Within
search errors were at a low level and not sig-
nificantly increased in any of the three
groups.
The measure of strategy employed in this
task was scored on a scale of 1-37, with lower
scores representing more efficient use of the
strategy. The best possible score of 1 was
obtained when, within each of the more diffi-
cult six and eight box problems, the same box
was used to initiate each search sequence.
Conversely, if every search within each of the
problems was started with a different box, the
maximum score of 37 was obtained. The
mean (SE) scores were 17-5 (074) for
patients with Parkinson's disease,
20-05 (0 84) for patients with SRO, and 16-6
(0.39) for those with multiple system atrophy.
Their corresponding control group means
(SE) were 15'1 (0 96), 16-4 (1-36) and
14-8 (0 20). Only the group with SRO dif-
fered significantly from their controls in terms
of this strategy measure (F (1,35) = 4.3,
p < 005), although in the Parkinsonian
group the difference approached significance
(F (1,46) = 3-96, p = 0052).
The relationship between the strategy score
and performance on the spatial working
memory task was further examined using
Pearson's product moment correlation coeffi-
cient, r. In the total control group, there was
a highly significant correlation between the
total number of between search errors and
the extent to which the strategy described
above was used (r = 0 74, p < 0-001).
Similarly, in patients with SRO, a positive
I.U)
0
G)Q
C.)
CA
a)a)
.0
0
Group
Figure 2 Between search errors on the spatial working
SRO_
- memory task for the groups with multiple system atrophySRO (MSA), Parkinson's disease (PD), and
control Steele-Richardson-Olszewski syndrome (SRO) and their
matched controls. Values shown at each level of difficulty
are mean numbers of between search errors (SE).
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correlation between these variE
found (SRO, r = 0-56, p < 001).
in the other two patient groups, the
such significant correlations betwei
and task performance, r = 0-46,
p > 0-05, respectively).
These results show that all thr
groups made significantly more
search errors' than their controls c
of spatial working memory. In all
this impairment may be related,
degrees, to inefficient use of a
repetitive searching strategy. Altl
index of strategy was only si
reduced in the group with SRO
sidiary correlational analysis of its r
to task performance showed clear;
ties in the other two groups.
PLANNING TASK
Across the 12 test problems, twe
relating to the number of moves r
reach solution were calculated. 'I
Figure 3 Mean (SE)
initial thinking times in
seconds on the Tower of
London tasks at various
levels of difficultyfor the
groups with multiple
system atrophy (MSA),
Parkinson's disease (PD)
and Steele-Richardson-
Olszewski syndrome
(SRO) and their matched
controls. Difficulty refers to
2,3,4, and 5 move
problems.
0-- MSA
0- MSA control
-0- PD
0- PD control
-4- SRO
0- SRO control
2 3
Difficulty
ables was number of moves above the minimum possi-
However, ble' provided a general measure of group per-
re were no formance at each level of difficulty. The
en strategy 'proportion of problems solved in the mini-
and 030, mum number of moves' provided more spe-
cific information about task difficulty and its
ree patient effect on the patient and control groups.
'between There were no significant differences
)n this test between any of the three patient groups and
three cases their respective controls in terms of the num-
in varying ber of moves to solution. In terms of the
particular number of problems solved in the minimum
hough the number of moves, only the group with SRO
ignificantly differed significantly from their control group
, the sub- (F (1,34) = 4-13, p < 005). In all groups,
elationship there were significant main effects of task dif-
abnormali- ficulty, although there were no significant
interactions between the task difficulty and
group factors.
Baseline measures of motor initiation time
measures and motor execution time were extracted
required to from the 12 "yoked control" trials. The
[he 'mean motor initiation time represented the mean
time between the onset of each problem and
the completion of the first selection-that is,
a correct touch of the required ball. For the
patient groups, average initial movement
times varied between 2-81 and 3-72 s for
patients with Parkinson's disease, 5 09 and
6-62 for patients with SRO, and 2-98 and
4-42 s for patients with multiple system
atrophy. Their corresponding control group
ranges were 2-35-4-13, 2-70-3-89, and
2-06-2-45 s. A similar pattern was found for
the subsequent movement time data.
The groups with SRO and multiple system
atrophy were significantly slower than their
controls both in terms of initial and subse-
quent movement time. The group with
Parkinson's disease were only significantly
impaired in terms of subsequent movement
time (F (1,31) = 4-66, p < 005).
The movement times discussed above were
used to derive estimates of planning or think-
A ~ ing time in the main task. Two main esti-
mates were calculated.
The initial thinking time was the interval
between the presentation of the problem and
the first touch of a ball, minus the corre-
sponding motor initiation time. The subse-
quent thinking time was the time between the
first touch of a ball and the completion of the
entire problem minus the total motor execu-
tion time derived from the corresponding
control problem. Because subsequent think-
ing time varied with the length of the prob-
lem, this measure was divided by the number
of moves actually made when tackling that
same problem to give an estimate of the
thinking time per move. The initial and sub-
A
' sequent thinking times for the three patient
groups and their controls are shown in figs 3
and 4.
The patients with Parkinson's disease and
SRO were significantly slower than their con-
trols in terms of the initial thinking time mea-
sure (F (1,42) = 5 03, p < 005 and (F(1,31)
i= 507, p < 005, respectively). In both cases,
there were significant main effects of task dif-
ficulty although there were no significant
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Figure 4 Mean (SE)
subsequent thinking times
in seconds on the Tower of
London tasks at various
levels of difficulty for the
groups with multiple
system atrophy (MSA),
Parkinson's disease (PD)
and Steele-Richardson-
Olszewski syndrome
(SRO) and their matched
controls. Difficulty refers to
2,3,4, and 5 move
problems.
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comparison with these two groups, the group
with SRO more closely resembles the group
with Parkinson's disease, although the effects
on thinking accuracy did not quite reach sig-
nificance for the latter.
ATTENTIONAL SET SHIFTING TEST
The incidences of subjects successfully com-
pleting each stage of the discrimination learn-
ing test are shown separately for each group
in fig 5. As can be seen, 82% of the control
group successfully completed the whole test,
whereas the three patient groups had signifi-
cantly lower success rates (55% for
Parkinson's disease; 56% for multiple system
atrophy; and 24% for SRO). Analysis of the
contingency table of raw scores using the like-
lihood ratio method revealed a highly signifi-
cant difference among the groups (2i =
27-70, df = 3, p < 0O001). Further analysis
using orthogonal contrasts showed that the
three patient groups were significantly differ-
T ent from the controls (2i = 20-91, df= 1).
The three patient groups were significantly
different among themselves (2i = 7-61, df =
2, p < 0.05), a result accounted for largely by
the inferior performance of the group with
SRO relative to the other two (2i = 6&75, df =
1, p < 0-01). When the incidence data were
analysed at each stage, taking into account
the number of subjects actually attempting
that stage, a qualitatively similar pattern of
results was obtained. Thus, for example, of
those subjects attempting the extradimen-
T stonal shift, there was again a significant over-
1*0*
0-9*
2 3 4 5
Difficulty
interactions between the task difficulty and
group factors. In contrast, only the group
with multiple system atrophy were signifi-
cantly slower than their controls in terms of
the subsequent thinking time measure
(F (1,30) = 11U24, p < 0 005). There were
significant interactions between task difficulty
and group in each of the patient groups
(F (3,90) = 3d14, p < 0-05 for multiple sys-
tem atrophy; (F (3,123) = 2-95, p < 0 05 for
Parkinson's disease; and F (3,90) = 2-81, p <
0-05 for SRO).
These results confirm that, although all
three patient groups had difficulty on this test
of planning ability, their impairments were
both quantitatively and qualitatively different.
Thus the patients with multiple system atro-
phy show significantly retarded subsequent
thinking time in the absence of deficits in ini-
tial thinking time or thinking accuracy,
whereas the Parkinson's patients show the
exact converse pattern of impairments. By
C
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c
-C
0~0QL
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Figure 5 Proportion of subjects successfully passing each
stage of the attention set shifting paradigm. Key: (C)
multiple system atrophy; (U) Parkinson's disease; (0)
Steele-Richardson-Olszewski syndrome; (0) controls. SD
= simple discrimination; SR = simple reversal; CID =
compound discrimination with separated elements; CD =
compound discrimination with superimposed elements;
CDR = compound discrimination reversal; IDS = intra-
dimensional shift; IDR = intra-dimensional shift reversal;
EDS = extra-dimensional shift; EDR = extra-dimensional
shift reversal. Note the large attrition in the patient groups
at the extra-dimensional shift.
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all group effect (2i = 21-59, df = 3, p <
0-001), and the controls were significantly
different from the combined patient groups
(2i= 17-15, df= 1, p < 0-001). Although
there was a clear tendency for the group with
SRO to perform worse (% success rates 70%
for Parkinson's diseases; 60% for multiple
system atrophy; and 33% for SRO) this did
not reach significance (2i = 4 30, df = 2, not
significant).
Discussion
This study has compared groups of patients
with different forms of basal ganglia disorder,
with control groups appropriately matched
for age and premorbid IQ, on three tests that
have been shown to be sensitive to frontal
lobe dysfunction. The three groups were
matched for general clinical disability, as
measured by the Hoehn and Yahr rating. The
results indicate that all three groups were
impaired on the tests of frontal lobe function,
although the precise pattern of deficits gener-
ally differed from those previously described
following neurosurgical damage to the frontal
lobes19 21 (table 2). There were minor qualita-
tive differences among the three forms of
basal ganglia disorder.
The frontal tests employed included a
computerised version of the Tower of
London planning task, adapted to measure
not only the efficiency of problem solving, but
also the speed of thinking, as reflected by the
latency to initiate solution attempts after cor-
rection for motor slowing using a yoked con-
trol task. Using similar methodology, it was
also possible to measure the time taken to
think about the problems during the
sequence of moves. These measures have pre-
viously distinguished patients with
Parkinson's disease from those with frontal
lobe damage.2'-24 Parkinsonian patients on
medication with relatively mild clinical dis-
ability-that is, Hoehn and Yahr ratings of 1
and 2-have been shown to be slower on the
initial thinking time measure, but to be no
less accurate than control subjects at solving
the problems,2'-24 whereas frontal lobe
patients exhibited no initial slowing of think-
ing, but showed impaired efficiency of prob-
lem solution and lengthened subsequent
thinking times.2' In addition to confirming
the lengthened initial thinking time of
Parkinsonian patients on medication, this
study, together with other results,2324 demon-
strates that those patients with more severe
clinical disability are also impaired in the
accuracy of solutions, as indexed by the mini-
mum moves measure, and to a minor degree,
in subsequent thinking time.
It is possible that the lengthened initial
thinking times in Parkinson's disease reflects
the clinical concept of bradyphrenia, this
having been discussed in some detail else-
where222' and so it was of particular interest
to compare the disease with SRO directly, as
slowing of thought processes has been consid-
ered to be a prominent feature of the second
condition. Our results indicate that, indeed
slowness of thinking is found in the group
with SRO; in fact their pattern of perfor-
mance on the Tower of London test of
lengthened initial thinking time, largely
unchanged subsequent thinking time and
impaired accuracy of problem solving, is simi-
lar to that of the Parkinsonian group matched
for overall clinical disability, the pattern in
both groups contrasting with that seen in
patients with frontal lobe damage.
Although the patients with SRO exhibited
lengthened initial thinking times, it was per-
haps surprising that their deficit was no
greater than in patients with Parkinson's dis-
ease, where bradyphrenia is a less prominent
clinical feature. This perhaps indicates that
bradyphrenia might represent a specific form
of cognitive slowing. It is of interest to note
that the patients with SRO in this study had
greatly lengthened latencies on the yoked
control task in comparison to the other two
patient groups, even despite their similar
degree of overall clinical disability. This task
itself had quite complex requirements which
effectively controlled for overall sensorimotor
slowing in the group with SRO. Nevertheless,
it is apparent that when the time spent actu-
ally planning the solutions to the problems is
corrected for these sensorimotor disabilities,
there is no obvious quantitative difference in
thinking time between the groups with
Parkinson's disease and SRO.
In general terms these neuropsychological
results are in agreement with those of other
investigators"338 although there are some dif-
ferences of detail and interpretation. For
example, Dubois et al,'3 in a comparative
study of 10 patients with SRO and 33 with
Parkinson's disease, used a similar type of
subtractive methodology to that employed by
us in the Tower of London task, but applied
instead to a choice reaction time paradigm.
Table 2 Summary of results and other studies
Unmedicated Medicated Alzheimer type
PD* PD MSA SRO Frontalt dementia
Span V x V x V x
Spatial working memory ('between search' errors) x x x x x x
Minimum move solutions (Tower of London) V V V x x x§
Initial thinking time (Tower of London) V x V x V x
Subsequent thinking time (Tower of London) x V x V x x
Attentional set shifting x x x x x VIx**
V = Unimpaired; x = Impaired. *From Owen et al, 199224; tFrom Owen et al, 199021, tFrom Sahgal et al, 199242; §From
Sahakian et al, unpublished results; IlFrom Owen et al, 199119; ¶mild DAT; **moderate DAT (from Sahakian et al, 1990.33 PD =
Parkinson's disease; MSA = multiple system atrophy; SRO = Steele-Richardson-Olszewsli syndrome; Frontal = Neurosurgical
lesion of frontal lobe.
85
Robbins,
_James, Owen, Lange, Lees, Leigh, Marsden, Quinn, Summers
This study showed that the patients with
SRO spent relatively longer than controls in a
measure of analysis time, which reflected the
additional central processing latency of more
complex reaction time contingencies for the
same motor response. No such effect was
found, in the patients with Parkinson's dis-
ease, however, although these had equivalent
Hoehn and Yahr disability ratings. It may
well be the case, as Dubois et al suggest, that
reaction time procedures are too simple for
patients with Parkinson's disease who usually
exhibit cognitive dysfunction only for com-
plex situations. Such procedures may be
more optimal for assessing bradyphrenia in
SRO, a possibility consistent with our present
observations of the poor performance of this
group on the yoked control task.
In related work, Blin et al 39 make a good
case that in SRO the fontal lobe like cognitive
deficits are in fact related to frontal metabolic
activity, rather than activity in the caudate
nucleus, as measured using positron emission
tomography. Unlike earlier studies with
smaller numbers of patients40 41 they found a
small but significant correlation between the
compound frontal score and an index of
frontal lobe activity, the frontal-occipital cor-
tex metabolic ratio. Although a relationship
between frontal lobe activity and performance
on our cognitive tests would not be surpris-
ing, it is apparent that the pattern of deficit
on the Tower of London task for the group
with SRO is not exactly the same as shown
for patients with frontal lobe damage. On the
other hand, our finding of impaired planning
accuracy in the group with SRO is not in
agreement with the view that 'problem solv-
ing behaviours appear[ed] relatively intact in
patients with SRO'(38, p. 557).
Although patients with Parkinson's disease
and SRO showed contrasting impairments to
those with frontal lobe lesions on the Tower
of London test, the patients with multiple
system atrophy, a condition involving diffuse
subcortical damage that includes the basal
ganglia, exhibited a comparable pattern, in
particular showing sparing of initial thinking
time, but slowing of subsequent thinking
time. There were, however, several difficulties
involved in making comparisons between the
patients with multiple system atrophy and the
other basal ganglia disorders, even though the
three groups were grossly matched for clinical
disability. In particular, these patients were
younger and were slightly more intelligent,
thus necessitating the use of separate IQ and
age-matched control groups. This resulted in
several problems, as spatial span, spatial
working memory and certain latency mea-
sures on the Tower of London task exhibited
obvious age-related changes. Thus, for exam-
ple, subsequent thinking time was impaired
in this group only relative to the performance
of their control group, rather than in absolute
terms. The pattern of change in the latency
scores for initial thinking time (where there
was no difference whatsoever from the con-
trol group) and subsequent thinking time,
was clearly distinct from that of the other two
patient groups. In addition, although the
spatial span of this group was comparable to
that of the control groups for SRO and
Parkinsonism, they were nevertheless worse
than their own control group, although this
trend did not reach significance.
The impairments in planning function
found in the three patient groups were also
paralleled by substantial deficits in the spatial
working memory task, as shown in particular
by the greatly increased numbers of between
search errors, which were comparable in
magnitude to those reported previously for
patients with frontal lobe damage.2' Within
search errors, however, which are elevated in
patients with frontal lobe damage, were at a
low level in each of the groups.
The spatial working memory task requires
a self-ordered, well-organised search to main-
tain high levels of performance, which pre-
sumably depends upon executive functions
such as the implementation of a searching
strategy. The deficits in performance on this
task in patients with frontal lobe damage
have indeed been related directly to such a
strategic impairment.2' This contrasts with
the performance of patients with probable
Alzheimer's disease who show no impair-
ments in the use of the same strategy, while
exhibiting massive deficits in spatial working
memory performance.42 Thus, it is apparent
that the contribution of both executive and
mnemonic factors to efficient performance
can be differentiated on this task. In terms of
the present study, the patients with basal gan-
glia disorders showed both types of deficit, in
varying degrees.
For example, the groups with SRO and
Parkinson's disease showed some impairment
in a measure of the efficient use of a well
defined strategy for mediating the spatial
working memory task, similar to patients with
frontal lobe damage.2' The normal positive
relationship between the use of this strategy
and spatial working memory performance was
absent in multiple system atrophy, however,
as well as in the Parkinsonian group. These
findings suggest that the spatial working
memory deficits in the second two groups
cannot simply be explained in terms of execu-
tive dysfunction, and reflect additional defi-
ciencies of spatial memory capacity.
The discrimination learning and set shift-
ing paradigm was also sensitive in detecting
deficits in each of the three groups, although
performance in the group with SRO was
especially weak, with only about 25% of the
patients successfully completing the entire
test. This deficit is especially significant,
because it cannot be attributed to the dis-
turbed eye movements in this disorder, as the
stimulus dimensions for the discrimination of
the compound stimuli were superimposed
and the time factor was not relevant. Many of
the failures on this test were due to the spe-
cial difficulty shown by the patients at the
extradimensional shift stage, when attentional
set has to be shifted to the formerly irrelevant
stimulus dimension. The deficit in
Parkinsonism has been reported previously,'8
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and it is important to note that it is present
even in the earliest stages of the disease,
before the onset of medication, being the
most sensitive of our frontal lobe tests to early
in the course Parkinson's disease.23 Moreover,
the deficit appears to be ameliorated by levo-
dopa.1834 Firstly, the performance of unmed-
icated, early in the course patients with
Parkinson's disease is, if anything, inferior to
that of patients on medication who are fur-
ther in the course of the disease.18 Secondly,
withdrawal of levodopa from severely affected
patients produced a selective and large deficit
in performance.34 Therefore, there is clearly a
dopaminergic component to performance on
this task.
These results are relevant to two aspects of
the present study. All of the Parkinson's
patients, most of the patients with multiple
system atrophy, but less than half of the
patients with SRO were receiving levodopa
(or bromocriptine) medication. Thus, the
degree of deficit in the first two groups may
have been masked to some extent. Therefore,
although the deficits in this paradigm were
greater in the group with SRO it is possible
that they would have been less evident in
comparison with unmedicated patients from
the other two groups. For the group with
SRO, 2/6 of the patients receiving dopamin-
ergic medication were successful, whereas
this was true for a smaller proportion (2/11)
of the remaining patients not receiving med-
ication, again consistent with some dopamin-
ergic benefit to performance on this task.
The attentional set shifting test is also of
some theoretical importance because, like the
Wisconsin card sorting test,3 it is relatively
insensitive to deficits early in the course of
Alzheimer's disease." Therefore, it appears
that this capacity is selectively impaired in
patients with basal ganglia and frontal lobe
dysfunction, and might be dependent on the
integrity of functional neuronal loops con-
necting the basal ganglia with the frontal
cortex.43
It should also be emphasized that the
deficits shown by our patient groups cannot
easily be attributed to global intellectual dete-
rioration. On routine clinical assessment, few
of the patients with multiple system atrophy
and none of the cases with Parkinson's dis-
ease showed evidence of any degree of
dementia. Moreover, there was little consis-
tent evidence of visual memory dysfunction in
the group with multiple system atrophy.25 On
the other hand, Parkinsonian patients, with
severe disability, do show significant decre-
ments in most of the tests in the CANTAB
visual memory battery.5 44 Therefore, it is
apparent that the cognitive deficits in
Parkinson's disease are broader in nature
than those in multiple system atrophy,
including impairments associated with corti-
cal regions other than the frontal lobe.
In the case of the group with SRO, approx-
imately half the patients showed a NART-
WAIS-R discrepancy of 10 or more points
and could be classified as having a significant
degree of generalized cognitive deterioration.
However, post hoc comparisons between the
two resultant subgroups failed to show any
significant differences in performance on the
three tests of frontal lobe function, with the
exception of minimum move solutions.
Therefore, it appears likely that more general-
ized dementia in the group with SRO is asso-
ciated with a different neural substrate than
the specific impairments of frontostriatal
function described here.
In conclusion, all three of these basal gan-
glia disorders show significant cognitive
impairments on tests sensitive to frontal lobe
dysfunction. Overall, the gross similarity in
the results of these computerised tests con-
trasts with the obvious clinical differences
associated with these diseases, but may indi-
cate a common and fundamental syndrome of
cognitive dysfunction, a frontostriatal demen-
tia. This is not a generalised dementia
because it contrasts markedly with that seen
in early Alzheimer's disease. Moreover, we
have shown that there are some qualitative
differences between the patterns of deficit in
these basal ganglia diseases which may indi-
cate subtle differences in underlying fronto-
striatal pathology.
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